Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
ELIL
Upturn stock ratingUpturn stock rating

Direxion Daily LLY Bull 2X Shares (ELIL)

Upturn stock ratingUpturn stock rating
$18.82
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

06/30/2025: ELIL (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $0

1 Year Target Price $0

Analysts Price Target For last 52 week
$0Target price
Low$
Current$18.82
high$

Analysis of Past Performance

Type Stock
Historic Profit 0%
Avg. Invested days 0
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 1.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 06/30/2025

Key Highlights

Company Size ETF
Market Capitalization 0 USD
Price to earnings Ratio -
1Y Target Price -
Price to earnings Ratio -
1Y Target Price -
Volume (30-day avg) -
Beta -
52 Weeks Range 15.91 - 26.62
Updated Date 04/5/2025
52 Weeks Range 15.91 - 26.62
Updated Date 04/5/2025
Dividends yield (FY) -
Basic EPS (TTM) -

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -

Management Effectiveness

Return on Assets (TTM) -
Return on Equity (TTM) -

Valuation

Trailing PE -
Forward PE -
Enterprise Value -
Price to Sales(TTM) -
Enterprise Value -
Price to Sales(TTM) -
Enterprise Value to Revenue -
Enterprise Value to EBITDA -
Shares Outstanding -
Shares Floating -
Shares Outstanding -
Shares Floating -
Percent Insiders -
Percent Institutions -

Analyst Ratings

Rating -
Target Price -
Buy -
Strong Buy -
Buy -
Strong Buy -
Hold -
Sell -
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

Direxion Daily LLY Bull 2X Shares

stock logo

Company Overview

overview logo History and Background

The Direxion Daily LLY Bull 2X Shares (LLYU) is an exchange-traded fund (ETF) that seeks daily investment results, before fees and expenses, of 200% of the daily performance of the common stock of Eli Lilly and Company (LLY). It was created and is managed by Direxion.

business area logo Core Business Areas

  • Leveraged ETF: LLYU is a leveraged ETF, meaning it uses financial derivatives and debt to amplify the returns of its underlying index, which is the daily performance of Eli Lilly (LLY) stock. It is not intended for long-term investment.

leadership logo Leadership and Structure

Direxion is the investment advisor for LLYU. The fund's performance is directly tied to the management strategies and decisions of Direxion. The organizational structure involves portfolio managers and analysts who track LLY and manage the fund's assets.

Top Products and Market Share

overview logo Key Offerings

  • Direxion Daily LLY Bull 2X Shares (LLYU): This ETF aims to deliver twice the daily return of Eli Lilly (LLY). Market share is not directly applicable to leveraged ETFs as it depends on trading volume and assets under management (AUM). Competitors are other leveraged and inverse ETFs focused on the pharmaceutical or healthcare sectors. Actual market share numbers are not publicly available.

Market Dynamics

industry overview logo Industry Overview

The ETF industry is highly competitive, with numerous providers offering various investment strategies. Leveraged ETFs cater to sophisticated investors seeking short-term gains.

Positioning

LLYU is positioned as a short-term trading tool for investors who are bullish on Eli Lilly (LLY). It's a niche product within the broader ETF market.

Total Addressable Market (TAM)

The TAM for leveraged ETFs is a fraction of the total ETF market. LLYU's position is tied to the trading interest in LLY and the demand for leveraged exposure. Estimating a precise TAM is difficult due to its dependence on trading activity.

Upturn SWOT Analysis

Strengths

  • Potential for high daily returns (2x LLY)
  • Provides leveraged exposure without margin account
  • Liquid and easily tradable

Weaknesses

  • High risk due to leverage
  • Erosion of value due to compounding (volatility drag)
  • Not suitable for long-term investment
  • High expense ratio

Opportunities

  • Increased investor interest in LLY
  • Short-term market rallies in LLY
  • Expansion of Direxion's ETF offerings

Threats

  • Decreasing investor interest in LLY
  • Regulatory changes affecting leveraged ETFs
  • Increased competition from similar products
  • Significant market downturn in LLY

Competitors and Market Share

competitor logo Key Competitors

  • None

Competitive Landscape

LLYU's advantage lies in providing leveraged exposure to LLY specifically. Its disadvantage is the inherent risk of leveraged ETFs and the potential for volatility drag.

Growth Trajectory and Initiatives

Historical Growth: Growth is tied to LLY's stock performance and investor demand for leveraged exposure.

Future Projections: Future performance depends on the outlook for LLY and the overall market sentiment towards leveraged ETFs.

Recent Initiatives: Direxion may launch similar ETFs tracking other companies or sectors, but specific initiatives related to LLYU are unlikely.

Summary

LLYU is a high-risk, high-reward ETF designed for short-term trading of Eli Lilly's stock. It offers leveraged exposure but suffers from volatility drag, making it unsuitable for long-term investment. Its performance hinges on LLY's daily price movements, and investors should be aware of the inherent risks before investing. Direxion offers a specific product and it performance is based on the success of Eli Lilly shares. This creates a very cyclical market position.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • DirexionShares.com
  • ETF.com
  • Yahoo Finance

Disclaimers:

Leveraged ETFs are not suitable for all investors. Past performance is not indicative of future results. Consult with a financial advisor before investing.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Direxion Daily LLY Bull 2X Shares

Exchange NASDAQ
Headquaters -
IPO Launch date 2025-03-26
CEO -
Sector -
Industry -
Full time employees -
Website
Full time employees -
Website

The fund, under normal circumstances, invests at least 80% of its net assets (plus any borrowings for investment purposes) in the securities of LLY and financial instruments, such as swap agreements and options, that, in combination, provide 2X daily leveraged exposure to LLY, consistent with the fund"s investment objective. The fund is non-diversified.